financetom
Business
financetom
/
Business
/
Deutsche Bank Gives Its Outlook of Bank of England Policy Action
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Deutsche Bank Gives Its Outlook of Bank of England Policy Action
Oct 22, 2024 12:10 PM

07:38 AM EDT, 10/22/2024 (MT Newswires) -- Deutsche Bank said it now shifted its call to a two-stage rate-cutting cycle at the Bank of England.

In Stage 1, the bank expects the BoE's Monetary Policy Committee to move the Bank Rate sequentially over the next few months, taking the Bank Rate down to 3.75% by May 2025.

Following that, in Stage 2, Deutsche Bank estimates the MPC to move to a quarterly pace of rate cuts all the way down to 3% -- the mid-point of the bank's medium-term neutral rate estimates.

The risk of 50bps rate cuts has risen in recent weeks, but the conditions for 'forceful' rate cuts have yet to be met, and the window for any outsized rate cuts is likely to be small, stated Deutsche Bank.

Importantly, the bank still sees risks skewed to a higher terminal rate -- especially in light of growing expectations of looser fiscal policy in the British Fall Budget -- with the MPC potentially pausing following Stage 1 of the easing cycle, or at 3.75%.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Eli Lilly's Mirikizumab Shows Long-Term Remission in Phase 3 Inflammatory Bowel Diseases Studies
Eli Lilly's Mirikizumab Shows Long-Term Remission in Phase 3 Inflammatory Bowel Diseases Studies
Nov 3, 2024
07:28 AM EDT, 10/28/2024 (MT Newswires) -- Eli Lilly ( LLY ) said Monday that phase 3 studies of its drug mirikizumab showed sustained stable, long-term remission in patients across two inflammatory bowel diseases, ulcerative colitis and Crohn's disease. One study showed that mirikizumab helped 81% of patients with moderately to severely active ulcerative colitis to maintain long-term clinical remission,...
PROCEPT BioRobotics Q3 Loss Narrows, Revenue Increases; Shares Up Pre-Bell
PROCEPT BioRobotics Q3 Loss Narrows, Revenue Increases; Shares Up Pre-Bell
Nov 3, 2024
07:28 AM EDT, 10/28/2024 (MT Newswires) -- PROCEPT BioRobotics ( PRCT ) reported a Q3 net loss Monday of $0.40 per diluted share, compared with a loss of $0.51 a year earlier. Analysts surveyed by Capital IQ expected a loss of $0.49. Revenue for the quarter ended Sept. 30 was $58.4 million, up from $35.1 million a year earlier. Analysts...
Boeing to raise up to $19 billion in stock offering to shore up finances
Boeing to raise up to $19 billion in stock offering to shore up finances
Nov 3, 2024
(Reuters) -Boeing on Monday launched a stock offering that could raise up to $19 billion as the planemaker looks to strengthen its finances squeezed by an over month-long worker strike and a year-long safety crisis. The company is offering 90 million in common stock and $5 billion in depositary shares, that represent an interest in convertible preferred stock. The company's...
Market Chatter: BlackRock, Canada Pension Board to Invest in $1.4 Billion in Swiggy IPO
Market Chatter: BlackRock, Canada Pension Board to Invest in $1.4 Billion in Swiggy IPO
Nov 3, 2024
07:03 AM EDT, 10/28/2024 (MT Newswires) -- BlackRock ( BLK ) and the Canada Pension Plan Investment Board plan to invest in the $1.4 billion initial public offering of Swiggy, the Indian food delivery firm, Reuters reported Sunday, citing sources close to the matter. Meanwhile, Swiggy lowered its IPO valuation to $11.3 billion, 25% below the previous target of $15...
Copyright 2023-2026 - www.financetom.com All Rights Reserved